Browse medicines
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Showing 1–7 of 7 records
Semaglutide (Ozempic / Wegovy / Rybelsus)
Peptide medicineApproved in the United States (FDA)Detailed recordUse listed on the medicine record
Type 2 diabetes, obesity, and heart and kidney risk that comes with them
Desmopressin (DDAVP / Stimate / Nocdurna / Noctiva)
Peptide medicineApproved in the United States (FDA)Detailed recordUse listed on the medicine record
Passing far too much urine because the body is missing the hormone that concentrates it — and, separately, bleeding in mild haemophilia A or mild von Willebrand disease
Liraglutide (Victoza / Saxenda)
Peptide medicineApproved in the United States (FDA)Detailed recordUse listed on the medicine record
Type 2 diabetes and long-term weight management
Dulaglutide (Trulicity)
Peptide medicineApproved in the United States (FDA)Detailed recordUse listed on the medicine record
Type 2 diabetes, including in people who have not yet had a heart attack
Exenatide (Byetta / Bydureon / Bydureon BCise)
Peptide medicineApproved in the United States (FDA)Detailed recordUse listed on the medicine record
Type 2 diabetes
Teriparatide (Forteo / Bonsity)
Peptide medicineApproved in the United States (FDA)Detailed recordUse listed on the medicine record
Severe bone thinning, where the aim is to build new bone rather than only slow its loss
Tirzepatide (Mounjaro / Zepbound)
Peptide medicineApproved in the United States (FDA)Detailed recordUse listed on the medicine record
Type 2 diabetes, obesity, and obesity-related sleep apnoea